يعرض 1 - 20 نتائج من 120 نتيجة بحث عن '"Supratik Basu"', وقت الاستعلام: 0.85s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
  3. 3
    Academic Journal
  4. 4
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
    Image
  19. 19
  20. 20

    المساهمون: CHU Lille, Leeds Institute of Cancer and Pathology [U.K.], The Levine Cancer Institute, Hôpital Haut-Lévêque [CHU Bordeaux], CHU Bordeaux [Bordeaux], Mayo Clinic [Rochester], University of Southern Denmark (SDU), Centre hospitalier universitaire de Nantes (CHU Nantes), University of Calgary, University of Wolverhampton, Karolinska University Hospital [Stockholm], Karolinska Institute, UniversitätsKlinikum Heidelberg, University of Melbourne, CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), University of Alberta, Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg] (UKE), Massachusetts General Hospital [Boston], Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Henri Mondor [Créteil], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Janssen Research & Development, Amsterdam UMC - Amsterdam University Medical Center, This study was sponsored by Janssen Research & Development, LLC. The authors thank the patients who participated in this study and their families, as well as the study co-investigators, research nurses, and coordinators at each of the clinical sites. Medical writing and editorial support were provided by Grace Wang, PharmD, of Cello Health Communications/MedErgy, and were funded by Janssen Global Services, LLC., Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Henri Mondor, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Amsterdam UMC, Hematology, CCA - Cancer Treatment and quality of life, Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Jonchère, Laurent

    المصدر: Leukemia
    Leukemia, 2022, 36 (4), pp.1066-1077. ⟨10.1038/s41375-021-01488-8⟩
    Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2022, ⟨10.1038/s41375-021-01488-8⟩
    Leukemia, 36(4), 1066-1077. Nature Publishing Group
    Facon, T, Cook, G, Usmani, S Z, Hulin, C, Kumar, S, Plesner, T, Touzeau, C, Bahlis, N J, Basu, S, Nahi, H, Goldschmidt, H, Quach, H, Mohty, M, Venner, C P, Weisel, K, Raje, N, Hebraud, B, Belhadj-Merzoug, K, Benboubker, L, Decaux, O, Manier, S, Caillot, D, Ukropec, J, Pei, H, van Rampelbergh, R, Uhlar, C M, Kobos, R & Zweegman, S 2022, ' Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma : frailty subgroup analysis of MAIA ', Leukemia, vol. 36, no. 4, pp. 1066-1077 . https://doi.org/10.1038/s41375-021-01488-8
    Facon, T, Cook, G, Usmani, S Z, Hulin, C, Kumar, S, Plesner, T, Touzeau, C, Bahlis, N J, Basu, S, Nahi, H, Goldschmidt, H, Quach, H, Mohty, M, Venner, C P, Weisel, K, Raje, N, Hebraud, B, Belhadj-Merzoug, K, Benboubker, L, Decaux, O, Manier, S, Caillot, D, Ukropec, J, Pei, H, Van Rampelbergh, R, Uhlar, C M, Kobos, R & Zweegman, S 2022, ' Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma : frailty subgroup analysis of MAIA ', Leukemia, vol. 36, pp. 1066-1077 . https://doi.org/10.1038/s41375-021-01488-8

    وصف الملف: application/pdf